These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 12976790)

  • 1. [Neurotropic affinity of Group B Coxsackie viruses and myotropic affinity of Type I Coxsackie viruses for newborn mice].
    LEVADITI C; HENRY-EVENO J
    Ann Inst Pasteur (Paris); 1952 Jun; 82(6):751-3. PubMed ID: 12976790
    [No Abstract]   [Full Text] [Related]  

  • 2. [Mechanism of the susceptibility of newborn mice and of the resistance of adult mice to neurotropic Group B Coxsackie virus].
    LEVADITI C; VAISMAN A; HENRY-EVENO J
    Ann Inst Pasteur (Paris); 1952 Jun; 82(6):754-6. PubMed ID: 12976791
    [No Abstract]   [Full Text] [Related]  

  • 3. [Interference of viruses CLM and TCLM in relation to Coxsackie virus type B (strain B1)].
    TURRISI E
    Riv Ist Sieroter Ital; 1959; 34():202-5. PubMed ID: 13839995
    [No Abstract]   [Full Text] [Related]  

  • 4. A comparative study of the prototypic Hill strain of ECHO virus, type 9, and several Coxsackie-like viruses related to it antigenically.
    ARCHETTI I; DUBES GR; WENNER HA
    Arch Gesamte Virusforsch; 1959; 9(1):73-91. PubMed ID: 13650542
    [No Abstract]   [Full Text] [Related]  

  • 5. NEUTRALIZING ANTIBODIES IN HUMAN SERA AGAINST ECHO 4, 6, 9, AND COXSACKIE A 7 VIRUSES.
    NIKOLAYEV VP
    J Hyg Epidemiol Microbiol Immunol; 1964; 8():516-20. PubMed ID: 14238950
    [No Abstract]   [Full Text] [Related]  

  • 6. ENTEROVIRUS INFECTIONS: ETIOLOGIC, EPIDEMIOLOGIC AND CLINICAL ASPECTS.
    HORSTMANN DM
    Calif Med; 1965 Jul; 103(1):1-8. PubMed ID: 14336786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SURVIVAL OF VIRUSES OF THE ENTEROVIRUS GROUP (POLIOMYELITIS, ECHO, COXSACKIE) IN SOIL AND ON VEGETABLES.
    BAGDASARYAN GA
    J Hyg Epidemiol Microbiol Immunol; 1964; 8():497-505. PubMed ID: 14238948
    [No Abstract]   [Full Text] [Related]  

  • 8. A-549 is a suitable cell line for primary isolation of coxsackie B viruses.
    Otero JR; Folgueira L; Trallero G; Prieto C; Maldonado S; Babiano MJ; Martinez-Alonso I
    J Med Virol; 2001 Nov; 65(3):534-6. PubMed ID: 11596090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The sensitivity of suckling mice and tissue cultures for isolation of Coxsackie B viruses.
    LYCKE E; LUND E; HULTGARDH A
    Arch Gesamte Virusforsch; 1959; 9():443-8. PubMed ID: 14419113
    [No Abstract]   [Full Text] [Related]  

  • 10. ALTERATION OF THE PATHOGENICITY OF SOME GROUP B COXSACKIE VIRUSES UNDER DIFFERENT CONDITIONS OF PASSAGE. I. VIRUS TYPE 4.
    VIZOSO AD; SANDERS FK
    Acta Virol; 1964 Jan; 8():38-45. PubMed ID: 14106020
    [No Abstract]   [Full Text] [Related]  

  • 11. Viral agents oncolytic for human tumors in heterologous host; oncolytic effect of Coxsackie B viruses.
    SUSKIND RG; HUEBNER RJ; ROWE WP; LOVE R
    Proc Soc Exp Biol Med; 1957 Feb; 94(2):309-18. PubMed ID: 13408245
    [No Abstract]   [Full Text] [Related]  

  • 12. [Diabetogenic properties of Coxsackie A13 and Coxsackie B4 viruses in experimental infection in mice].
    Bocharov EF; Shorin IuP; Solodovnikova IA; Kazarian LS; Seliatitskaia VG
    Vopr Virusol; 1988; 33(4):469-74. PubMed ID: 2848368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PRODUCTION AND STANDARDIZATION OF ANTISERA TO THE ECHO AND COXSACKIE GROUP B VIRUSES.
    HAMBLING MH; PORTER AA; DAVIS PM; MACRAE AD
    Mon Bull Minist Health Public Health Lab Serv; 1965 Jan; 24():15-20. PubMed ID: 14270697
    [No Abstract]   [Full Text] [Related]  

  • 14. [Myocarditis and meningoencephalitis in newborn infants caused by Coxsackie virus B 3].
    LUKES J
    Cesk Pediatr; 1959 Aug; 14():731-5. PubMed ID: 14418848
    [No Abstract]   [Full Text] [Related]  

  • 15. [Determination of antibodies to Coxsackie and ECHO viruses by the color test and cytopathic action].
    ZUBOVA ZF; GORDIENKO NM; BORUTSKAIA TR
    Vopr Virusol; 1963; 8():104-8. PubMed ID: 14004011
    [No Abstract]   [Full Text] [Related]  

  • 16. Myocarditis and encephalitis in newborn infants, caused by Coxsackie B virus.
    VANEK J; LUKES J; POTUZNIK V; POLEDNIKOVA I; VILIM V
    J Hyg Epidemiol Microbiol Immunol; 1959; 3():283-91. PubMed ID: 13841241
    [No Abstract]   [Full Text] [Related]  

  • 17. [CYCLES OF MULTIPLICATION AND THE MECHANISM OF SPREAD OF GROUP B COXSACKIE VIRUSES IN TISSUE CULTURE].
    GORDIENKO NM; ANDZHAPARIDZE OG
    Vopr Virusol; 1964; 126():301-6. PubMed ID: 14237279
    [No Abstract]   [Full Text] [Related]  

  • 18. Response of germ-free animals to experimental virus monocontamination. I. Observation on Coxsackie B virus.
    SCHAFFER J; BEAMER PR; TREXLER PC; BREIDENBACH G; WALCHER DN
    Proc Soc Exp Biol Med; 1963 Mar; 112():561-4. PubMed ID: 13976644
    [No Abstract]   [Full Text] [Related]  

  • 19. Identification of serotype-specific and nonserotype-specific B-cell epitopes of coxsackie B virus using synthetic peptides.
    Haarmann CM; Schwimmbeck PL; Mertens T; Schultheiss HP; Strauer BE
    Virology; 1994 May; 200(2):381-9. PubMed ID: 7513917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [ENTEROVIRUSES--POLIOVIRUSES, COXSACKIE VIRUSES, ECHO VIRUSES. BIOLOGICAL PROPERTIES AND CLINICAL AND EPIDEMIOLOGICAL ASPECTS OF INFECTIONS].
    JABLONSKI L
    Pol Tyg Lek; 1963 Oct; 18():1572-6. PubMed ID: 14101678
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.